Effect of race on the outcome of pediatric patients with Hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 26, Issue 8, 2008, Pages 1282-1288

  Metzger, Monika L ^a   Castellino, Sharon M ^a   Hudson, Melissa M ^a   Rai, Shesh N ^a   Kaste, Sue C ^a   Krasin, Matthew J ^a   Kun, Larry E ^a   Pui, Ching Hon ^a   Howard, Scott C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CANCER SURVIVAL; CHILD; ETHNICITY; EUROPEAN AMERICAN; FEMALE; HEMOGLOBIN BLOOD LEVEL; HODGKIN DISEASE; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE DIFFERENCE; TERTIARY HEALTH CARE; CAUCASIAN; ETHNOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; NEGRO; PRESCHOOL CHILD; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SOCIOECONOMICS; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HODGKIN DISEASE; HUMANS; MALE; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 41649095013     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.0699     Document Type: Article

References (33)

1. Aplenc R, Alonzo TA, Gerbing RB, et al: Ethnicity and survival in childhood acute myeloid leukemia: A report from the Children's Oncology Group. Blood 108:74-80, 2006
2. Baker KS, Anderson JR, Lobe TE, et al: Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 20:4428-4433, 2002
3. Barnholtz-Sloan JS, Severson RK, Stanton B, et al: Pediatric brain tumors in non-Hispanics, Hispanics, African Americans and Asians: Differences in survival after diagnosis. Cancer Causes Control 16:587-592, 2005
4. Pui CH, Boyett JM, Hancock ML, et al: Outcome of treatment for childhood cancer in black as compared with white children: The St Jude Children's Research Hospital experience, 1962 through 1992. JAMA 273:633-637, 1995
5. Rubnitz JE, Lensing S, Razzouk BI, et al: Effect of race on outcome of white and black children with acute myeloid leukemia: The St Jude experience. Pediatr Blood Cancer 48:10-15, 2007
6. Bhatia S, Sather HN, Heerema NA, et al: Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100:1957-1964, 2002
7. Pollock BH, DeBaun MR, Camitta BM, et al: Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group Study. J Clin Oncol 18:813-823, 2000
8. Percy CL, Smith MA, Linet M, et al: Lymphomas and reticuloendothelial neoplasms, in Ries LA, Smith MA, Gurney JG, et al (eds): Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD, National Cancer Institute, NIH publication 99-4649, 1999
9. Pui CH, Sandlund JT, Pei D, et al: Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA 290:2001-2007, 2003
10. Donaldson SS, Hudson MM, Lamborn KR, et al: VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: Results of a prospective clinical trial. J Clin Oncol 20:3081-3087, 2002
11. Hudson MM, Krasin M, Link MP, et al: Risk-adapted, combined-modality therapy with VAMP/ COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol 22:4541-4550, 2004
12. Hudson M, Greenwald C, Thompson E, et al: Efficacy and toxicity of multiagent (COP/ABVD) chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 11:100-108, 1993
13. Horning SJ, Hoppe RT, Breslin S, et al: Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial. J Clin Oncol 20:630-637, 2002
14. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860-1861, 1971
15. United States Census Bureau. http://www.census.gov
16. Agresti A: An Introduction To Categorical Data Analysis. New York, NY, John Wiley & Sons, 2002
17. Smith RS, Chen Q, Hudson MM, et al: Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol 21:2026-2033, 2003
18. Cox DR: Regression models and life-tables. J Roy Stat Soc B 34:187-220, 1972
19. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Kadan-Lottick NS, Ness KK, Bhatia S, et al: Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 290:2008-2014, 2003
21. Pui CH, Crist WM, Look AT: Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 76:1449-1463, 1990
22. Pui CH, Behm FG, Crist WM: Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 82:343-362, 1993
23. Zaki A, Natarajan N, Mettlin CJ: Early and late survival in Hodgkin's disease among whites and blacks living in the United States. Cancer 72:602-606, 1993
24. Krasin MJ, Rai SN, Kun LE, et al: Patterns of treatment failure in pediatric and young adult patients with Hodgkin's disease: Local disease control with combined-modality therapy. J Clin Oncol 23:8406-8413, 2005
25. Bhatia S, Yasui Y, Robison LL, et al: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group. J Clin Oncol 21:4386-4394, 2003
26. Castellino SM, Casillas J, Hudson MM, et al: Minority adult survivors of childhood cancer: A comparison of long-term outcomes, health care utilization, and health-related behaviors from the childhood cancer survivor study. J Clin Oncol 23:6499-6507, 2005
27. Bassal M, Mertens AC, Taylor L, et al: Risk of selected subsequent carcinomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol 24:476-483, 2006
28. Foss AA, Andersen A, Nome O, et al: Long-term risk of second malignancy after treatment of Hodgkin's disease: The influence of treatment, age and follow-up time. Ann Oncol 13:1786-1791, 2002
29. Metayer C, Lynch CF, Clarke EA, et al: Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18:2435-2443, 2000
30. Berquist RK, Berquist WE, Esquivel CO, et al: Adolescent non-adherence: Prevalence and consequences in liver transplant recipients. Pediatr Transplant 10:304-310, 2006
31. Schwartz RS: Racial profiling in medical research. N Engl J Med 344:1392-1393, 2001
32. Rebbeck TR, Halbert CH, Sankar P: Genetics, epidemiology, and cancer disparities: Is it black and white? J Clin Oncol 24:2164-2169, 2006
33. Witzig R: The medicalization of race: Scientific legitimization of a flawed social construct. Ann Intern Med 125:675-679, 1996